CRISIL Reports Q2 Net Profit Of ₹205 Crore And Declares ₹17 Dividend
CRISIL delivered a solid Q2 performance with consolidated net profit rising 7.89% YoY to ₹205 crore, meeting analyst expectations. Top-line revenue expanded 20.33% YoY to ₹1,095 crore, while operating EBITDA grew to ₹300 crore. The board approved a third interim dividend of ₹17 per equity share.
Market snapshot: CRISIL reported a consolidated net profit of ₹205 crore for the second quarter, representing a 7.89% YoY growth from ₹190 crore in the prior-year period and matching street estimates. Consolidated revenue from operations increased 20.33% YoY to ₹1,095 crore alongside an interim dividend declaration of ₹17 per equity share.
Data Snapshot
- Consolidated Net Profit stood at ₹205 crore versus ₹190 crore in the year-ago quarter, matching market estimates.
- Consolidated Revenue from operations reached ₹1,095 crore compared to ₹910 crore in Q2 of the previous year.
- Operating EBITDA increased to ₹300 crore from ₹260 crore YoY, with EBITDA margin coming in at 27.51% versus 28.87% YoY.
- Board declared a third interim dividend of ₹17 per equity share for the financial year.
What's Changed
- Consolidated top-line revenue expanded by ₹185 crore YoY, crossing ₹1,000 crore quarterly run-rate.
- Operating EBITDA expanded by ₹40 crore YoY to ₹300 crore, although EBITDA margin contracted by 136 basis points YoY to 27.51%.
- Net profit increased by ₹15 crore YoY to ₹205 crore, fulfilling consensus market estimates.
Key Takeaways
- Revenue growth of 20.33% YoY underlines steady demand across credit ratings, risk analytics, and research services.
- Absolute EBITDA expanded by 15.38% YoY despite minor operational margin compression.
- Sustained shareholder payout momentum with an interim dividend of ₹17 per share.
SAHI Perspective
CRISIL's Q2 results highlight strong revenue momentum surpassing ₹1,000 crore in a single quarter. While EBITDA margin moderated by 136 bps to 27.51%, double-digit revenue expansion enabled absolute EBITDA and net profit growth in line with estimates, reinforcing its core earnings stability.
Market Implications
Operational performance reflects healthy demand for ratings and financial market research amid active corporate debt issuances in India. The declared dividend of ₹17 per equity share underscores dependable cash generation, supporting investor sentiment in high-quality market intermediaries.
Trading Signals
Market Bias: Bullish
Top-line revenue expansion of 20.33% YoY to ₹1,095 crore and net profit meeting estimates at ₹205 crore signal operational health. An interim dividend payout of ₹17 per share further strengthens cash flow confidence.
Overweight: Financial Analytics, Credit Rating Agencies
Trigger Factors:
- Sustained domestic corporate bond issuance volumes
- Margin stabilization back above 28%
- Global demand for risk and analytics solutions
Time Horizon: Near-term (0-3 months)
Industry Context
Credit rating agencies and market analytics providers continue to benefit from healthy corporate debt market activity and rising demand for independent risk evaluation. CRISIL's strategic alignment with parent S&P Global provides key advantages in cross-border financial intelligence.
Key Risks to Watch
- Operating margin compression if employee and technology expenses outpace revenue growth.
- Potential slowdown in corporate debt issuances impacting ratings volume.
Recent Developments
CRISIL provided updates on the amalgamation of its step-down subsidiaries Crisil Canada Inc. and Crisil PriceMetrix Inc., as disclosed in exchange filings.
Closing Insight
CRISIL continues to demonstrate dependable execution with top-line growth exceeding 20% YoY. The combination of earnings alignment with estimates and consistent dividend distribution reinforces its position as a resilient capital markets play.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
Recent
Hyundai And Kia Struggle To Revive China Sales Amid EV Competition
Brown-Forman Bets On India's Growing Premium Spirits Market
Biocon Gains Approval For Yesintek Biosimilar To Stelara In New Global Markets
Shriram Finance Q2 PAT Rises 60% YoY to ₹3,680 Crore; Cuts FY27 AUM Guidance
IDFC First Bank Q2 PAT Rises 196.5% YoY to ₹10.45 Billion
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.